Clinical Trials Directory

Trials / Completed

CompletedNCT03613038

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Understanding Communication and Cognitive Impairments in Neurodegenerative Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
19 Years – 90 Years
Healthy volunteers
Accepted

Summary

The goal is to improve the fundamental knowledge about articulatory motor performance in people with Lou Gehrig's disease (also known as ALS) and Parkinson's disease (PD), in order to develop more sensitive assessments for progressive speech loss, which may lead to the improved timing of speech therapies.

Detailed description

The long-term goal is to optimize dysarthria assessment by improving the early detection and tracking of articulatory performance in progressive dysarthrias. The short-term goal of the proposed cross-sectional study is to focus on ALS and PD and quantify articulatory kinematic performance as a function of phonetic complexity, which is experimentally manipulated based on theoretical principles of speech motor development. The research strategy is to use 3D electromagnetic articulography to examine phonetic complexity effects of single word stimuli at the articulatory kinematic level in 15 talkers each with preclinical, mild, and moderate dysarthria, relative to 45 controls. The central hypothesis is that as dysarthria severity increases the discrepancy in articulatory performance, indexed by movement speed, distance, coordination, and variability, between people with dysarthria and typical controls will significantly increase at a lower phonetic complexity level.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhonetic complexity effects on speech motor performanceUse of 3D electromagnetic articulography to examine phonetic complexity effects of single word stimuli at the articulatory kinematic level in talkers each with preclinical, mild, and moderate dysarthria, relative to healthy controls.

Timeline

Start date
2017-07-15
Primary completion
2022-02-28
Completion
2022-02-28
First posted
2018-08-02
Last updated
2022-05-17

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03613038. Inclusion in this directory is not an endorsement.